These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 14676330)

  • 1. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.
    Tanaka T; Yamamoto J; Iwasaki S; Asaba H; Hamura H; Ikeda Y; Watanabe M; Magoori K; Ioka RX; Tachibana K; Watanabe Y; Uchiyama Y; Sumi K; Iguchi H; Ito S; Doi T; Hamakubo T; Naito M; Auwerx J; Yanagisawa M; Kodama T; Sakai J
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15924-9. PubMed ID: 14676330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
    Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
    Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells.
    Dimopoulos N; Watson M; Green C; Hundal HS
    FEBS Lett; 2007 Oct; 581(24):4743-8. PubMed ID: 17869249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle.
    Ye JM; Tid-Ang J; Turner N; Zeng XY; Li HY; Cooney GJ; Wulff EM; Sauerberg P; Kraegen EW
    Br J Pharmacol; 2011 Jun; 163(3):556-66. PubMed ID: 21265823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta.
    Muoio DM; MacLean PS; Lang DB; Li S; Houmard JA; Way JM; Winegar DA; Corton JC; Dohm GL; Kraus WE
    J Biol Chem; 2002 Jul; 277(29):26089-97. PubMed ID: 12118038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
    Chen W; Wang LL; Liu HY; Long L; Li S
    Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):240-6. PubMed ID: 18684227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.
    Krämer DK; Al-Khalili L; Guigas B; Leng Y; Garcia-Roves PM; Krook A
    J Biol Chem; 2007 Jul; 282(27):19313-20. PubMed ID: 17500064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effect of Unsaturated Fatty Acids on Palmitic Acid-Induced Toxicity in Skeletal Muscle Cells is not Mediated by PPARδ Activation.
    Tumova J; Malisova L; Andel M; Trnka J
    Lipids; 2015 Oct; 50(10):955-64. PubMed ID: 26255030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.
    Wang YX; Lee CH; Tiep S; Yu RT; Ham J; Kang H; Evans RM
    Cell; 2003 Apr; 113(2):159-70. PubMed ID: 12705865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos.
    Idrees M; Xu L; El Sheikh M; Sidrat T; Song SH; Joo MD; Lee KL; Kong IK
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction.
    Zizola C; Kennel PJ; Akashi H; Ji R; Castillero E; George I; Homma S; Schulze PC
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1078-85. PubMed ID: 25713305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
    Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
    Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.
    Risérus U; Sprecher D; Johnson T; Olson E; Hirschberg S; Liu A; Fang Z; Hegde P; Richards D; Sarov-Blat L; Strum JC; Basu S; Cheeseman J; Fielding BA; Humphreys SM; Danoff T; Moore NR; Murgatroyd P; O'Rahilly S; Sutton P; Willson T; Hassall D; Frayn KN; Karpe F
    Diabetes; 2008 Feb; 57(2):332-9. PubMed ID: 18024853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
    Nagasawa T; Inada Y; Nakano S; Tamura T; Takahashi T; Maruyama K; Yamazaki Y; Kuroda J; Shibata N
    Eur J Pharmacol; 2006 Apr; 536(1-2):182-91. PubMed ID: 16574099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAIBA attenuates insulin resistance and inflammation induced by palmitate or a high fat diet via an AMPK-PPARδ-dependent pathway in mice.
    Jung TW; Hwang HJ; Hong HC; Yoo HJ; Baik SH; Choi KM
    Diabetologia; 2015 Sep; 58(9):2096-105. PubMed ID: 26105792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional regulation and role of peroxisome proliferator-activated receptor delta in fatty acid catabolism in skeletal muscle.
    Holst D; Luquet S; Nogueira V; Kristiansen K; Leverve X; Grimaldi PA
    Biochim Biophys Acta; 2003 Jul; 1633(1):43-50. PubMed ID: 12842194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice.
    Jung TW; Lee SH; Kim HC; Bang JS; Abd El-Aty AM; Hacımüftüoğlu A; Shin YK; Jeong JH
    Exp Mol Med; 2018 Sep; 50(9):1-11. PubMed ID: 30213948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta.
    Krämer DK; Al-Khalili L; Perrini S; Skogsberg J; Wretenberg P; Kannisto K; Wallberg-Henriksson H; Ehrenborg E; Zierath JR; Krook A
    Diabetes; 2005 Apr; 54(4):1157-63. PubMed ID: 15793256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
    Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA
    Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.